# Johnson & Johnson Stock Rallies: Unpacking Recent Gains and Q2 Earnings Success
Explore how Johnson & Johnson (JNJ) stock climbs to $167.93 amid increased trading volume and strong Q2 results. Our latest podcast episode analyzes JNJ's impressive 5.8% year-over-year revenue growth to $24 billion and EPS of $2.77, which exceeded analyst expectations. Learn why pharmaceutical and medical device sales are thriving post-consumer health divestiture, and understand what Wall Street's mixed but generally positive outlook means for investors. With UBS and Goldman Sachs raising price targets while the stock offers a 3.14% dividend yield, discover whether this blue-chip staple deserves a place in your portfolio despite ongoing litigation concerns. Perfect for income-focused investors and those tracking healthcare sector performance.
For more http://www.quietplease.ai
Stock up on these deals
https://amzn.to/3QFpYIX
This content was created in partnership and with the help of Artificial Intelligence AI
